Rexulti 2 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FXUA2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,144
Award facts
- Contract value 100% obligated
- $7,143.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,143.68 to AmerisourceBergen Drug Corp for the supply of Rexulti (brexpiprazole) 2 mg tablets in a 30-count package. This firm fixed-price contract, awarded on January 14, 2026, with completion scheduled for January 15, 2026, represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Rexulti is an atypical antipsychotic medication used in the treatment of schizophrenia and major depressive disorder, supporting the military healthcare system's pharmaceutical supply requirements.
This delivery order is a child contract under AmerisourceBergen Drug Corp, which operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen). AmerisourceBergen holds a $999,999,999 prime IDC with DLA Troop Support Medical extending through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The contractor's extensive federal portfolio demonstrates its established capability to supply brand-name and generic medications, specialty pharmaceuticals, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a competitively awarded basis.
Quick answers
Who was awarded contract SPE2DR26FXUA2?
SPE2DR26FXUA2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FXUA2 worth?
The government has obligated $7,144 on SPE2DR26FXUA2.
Is contract SPE2DR26FXUA2 an order under another contract?
Yes. SPE2DR26FXUA2 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUA2 competed?
The extent of competition for SPE2DR26FXUA2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award